These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36916971)

  • 1. Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.
    Jia Q; Bielefeldt-Ohmann H; Maison RM; Hartwig A; Masleša-Galić S; Bowen RA; Horwitz MA
    Microbiol Spectr; 2023 Mar; 11(2):e0503522. PubMed ID: 36916971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LVS Δ
    Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA
    mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
    Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
    Cell Rep; 2021 Jul; 36(3):109400. PubMed ID: 34245672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants.
    Beavis AC; Li Z; Briggs K; Huertas-Díaz MC; Wrobel ER; Najera M; An D; Orr-Burks N; Murray J; Patil P; Huang J; Mousa J; Hao L; Hsiang TY; Gale M; Harvey SB; Tompkins SM; Hogan RJ; Lafontaine ER; Jin H; He B
    bioRxiv; 2022 Jun; ():. PubMed ID: 35702147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model.
    Langel SN; Johnson S; Martinez CI; Tedjakusuma SN; Peinovich N; Dora EG; Kuehl PJ; Irshad H; Barrett EG; Werts AD; Tucker SN
    Sci Transl Med; 2022 Aug; 14(658):eabn6868. PubMed ID: 35511920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease.
    Warner BM; Santry LA; Leacy A; Chan M; Pham PH; Vendramelli R; Pei Y; Tailor N; Valcourt E; Leung A; He S; Griffin BD; Audet J; Willman M; Tierney K; Albietz A; Frost KL; Yates JGE; Mould RC; Chan L; Mehrani Y; Knapp JP; Minott JA; Banadyga L; Safronetz D; Wood H; Booth S; Major PP; Bridle BW; Susta L; Kobasa D; Wootton SK
    iScience; 2021 Nov; 24(11):103219. PubMed ID: 34632328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants.
    Wussow F; Kha M; Faircloth K; Nguyen VH; Iniguez A; Martinez J; Park Y; Nguyen J; Kar S; Andersen H; Lewis MG; Chiuppesi F; Diamond DJ
    iScience; 2022 Jun; 25(6):104457. PubMed ID: 35634578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and Protective Efficacy of a Single Intranasal Dose Vectored Vaccine Based on Sendai Virus (Moscow Strain) against SARS-CoV-2 Variant of Concern.
    Kochneva GV; Kudrov GA; Zainutdinov SS; Shulgina IS; Shipovalov AV; Zaykovskaya AV; Borgoyakova MB; Starostina EV; Bodnev SA; Sivolobova GF; Grazhdantseva AA; Ivkina DI; Zadorozhny AM; Karpenko LI; P'yankov OV
    Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.
    Hassan AO; Feldmann F; Zhao H; Curiel DT; Okumura A; Tang-Huau TL; Case JB; Meade-White K; Callison J; Chen RE; Lovaglio J; Hanley PW; Scott DP; Fremont DH; Feldmann H; Diamond MS
    Cell Rep Med; 2021 Apr; 2(4):100230. PubMed ID: 33754147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges.
    Warner BM; Yates JGE; Vendramelli R; Truong T; Meilleur C; Chan L; Leacy A; Pham PH; Pei Y; Susta L; Wootton SK; Kobasa D
    NPJ Vaccines; 2024 May; 9(1):90. PubMed ID: 38782986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters.
    Wuertz KM; Barkei EK; Chen WH; Martinez EJ; Lakhal-Naouar I; Jagodzinski LL; Paquin-Proulx D; Gromowski GD; Swafford I; Ganesh A; Dong M; Zeng X; Thomas PV; Sankhala RS; Hajduczki A; Peterson CE; Kuklis C; Soman S; Wieczorek L; Zemil M; Anderson A; Darden J; Hernandez H; Grove H; Dussupt V; Hack H; de la Barrera R; Zarling S; Wood JF; Froude JW; Gagne M; Henry AR; Mokhtari EB; Mudvari P; Krebs SJ; Pekosz AS; Currier JR; Kar S; Porto M; Winn A; Radzyminski K; Lewis MG; Vasan S; Suthar M; Polonis VR; Matyas GR; Boritz EA; Douek DC; Seder RA; Daye SP; Rao M; Peel SA; Joyce MG; Bolton DL; Michael NL; Modjarrad K
    bioRxiv; 2021 Jun; ():. PubMed ID: 34159328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection.
    Nuñez IA; Lien CZ; Selvaraj P; Stauft CB; Liu S; Starost MF; Wang TT
    mSphere; 2021 Jun; 6(3):e0050721. PubMed ID: 34133199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
    Wuertz KM; Barkei EK; Chen WH; Martinez EJ; Lakhal-Naouar I; Jagodzinski LL; Paquin-Proulx D; Gromowski GD; Swafford I; Ganesh A; Dong M; Zeng X; Thomas PV; Sankhala RS; Hajduczki A; Peterson CE; Kuklis C; Soman S; Wieczorek L; Zemil M; Anderson A; Darden J; Hernandez H; Grove H; Dussupt V; Hack H; de la Barrera R; Zarling S; Wood JF; Froude JW; Gagne M; Henry AR; Mokhtari EB; Mudvari P; Krebs SJ; Pekosz AS; Currier JR; Kar S; Porto M; Winn A; Radzyminski K; Lewis MG; Vasan S; Suthar M; Polonis VR; Matyas GR; Boritz EA; Douek DC; Seder RA; Daye SP; Rao M; Peel SA; Joyce MG; Bolton DL; Michael NL; Modjarrad K
    NPJ Vaccines; 2021 Oct; 6(1):129. PubMed ID: 34711815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters.
    Liao HC; Shen KY; Yang CH; Chiu FF; Chiang CY; Chai KM; Huang WC; Ho HM; Chen YH; Huang MS; Liao CL; Chen HW; Huang MH; Liu SJ
    Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101169. PubMed ID: 38187094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters.
    Leventhal SS; Clancy C; Erasmus J; Feldmann H; Hawman DW
    Microorganisms; 2021 May; 9(5):. PubMed ID: 34065996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and Passive Immunization of Syrian Hamsters with An Attenuated SARS-CoV-2 Protects against New Variants of Concern.
    Wang T; Stauft C; Selvaraj P; D'agnillo F; Meseda C; Sangare K; Pedro C; Liu S; Lien C; Weir J; Starost M
    Res Sq; 2022 Nov; ():. PubMed ID: 36380761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern.
    O'Donnell KL; Gourdine T; Fletcher P; Shifflett K; Furuyama W; Clancy CS; Marzi A
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection.
    Suvorov A; Loginova S; Leontieva G; Gupalova T; Desheva Y; Korzhevskii D; Kramskaya T; Bormotova E; Koroleva I; Kopteva O; Kirik O; Shchukina V; Savenko S; Kutaev D; Borisevitch S
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal S; Wilson D; Shaia C; Randall S; Khandhar AP; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    bioRxiv; 2021 Dec; ():. PubMed ID: 34931189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c.
    Bahramali G; Mashhadi Abolghasem Shirazi M; Hannan M; Aghasadeghi MR; Khosravy MS; Arjmand S; Sadat SM
    Pathog Dis; 2023 Jan; 81():. PubMed ID: 37667486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.